Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 05-2025 | 05-2024 | 05-2023 | 05-2022 | 05-2021 | |
| Sales | 0 | 0 | 0 | 266 | 0 |
| Cost of Goods | N/A | N/A | N/A | 53 | N/A |
| Gross Profit | N/A | N/A | N/A | 213 | N/A |
| Operating Expenses | -9,661 | 18,058 | 40,576 | 145,670 | 104,596 |
| Operating Income | 9,661 | -18,058 | -40,576 | -145,404 | -104,596 |
| Interest Expense | 4,856 | 8,891 | 15,508 | 24,182 | 61,241 |
| Other Income | -1,060 | -22,892 | -23,740 | -41,234 | -10,628 |
| Pre-tax Income | 3,745 | -49,841 | -79,824 | -210,820 | -176,465 |
| Net Income Continuous | 3,745 | -49,841 | -79,824 | -210,820 | -176,465 |
| Net Income | $3,745 | $-49,841 | $-79,824 | $-210,820 | $-176,465 |
| EPS Basic Total Ops | 0.00 | -0.05 | -0.10 | -0.31 | -0.30 |
| EPS Basic Continuous Ops | 0.00 | -0.05 | -0.10 | -0.31 | -0.30 |
| EPS Diluted Total Ops | 0.00 | -0.05 | -0.10 | -0.31 | -0.30 |
| EPS Diluted Continuous Ops | 0.00 | -0.05 | -0.10 | -0.31 | -0.30 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.05 | -0.10 | N/A | -0.25 |
| EBITDA(a) | $10,086 | $-16,381 | $-38,206 | $-141,578 | $-89,094 |